help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WOOD, L. J.
Right arrow Articles by O'BYRNE, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WOOD, L. J.
Right arrow Articles by O'BYRNE, P. M.

Am. J. Respir. Crit. Care Med., Volume 159, Number 5, May 1999, 1457-1463

An Inhaled Corticosteroid, Budesonide, Reduces Baseline but Not Allergen-induced Increases in Bone Marrow Inflammatory Cell Progenitors in Asthmatic Subjects

LORNA J. WOOD, ROMA SEHMI, GAIL M. GAUVREAU, RICHARD M. WATSON, RONAN FOLEY, JUDAH A. DENBURG, and PAUL M. O'BYRNE

Asthma Research Group, Department of Medicine, McMaster University, Hamilton, Ontario, Canada

We have previously shown that allergen inhalation by asthmatics is associated with increases in bone marrow eosinophil/basophil colony-forming cells (Eo/B-CFU), and increases in CD34+ hemopoietic progenitors expressing the alpha -subunit of the IL-5 receptor (IL-5Ralpha ). This study investigated the effect of inhaled corticosteroid on baseline numbers and allergen-induced increases in these parameters. Nine subjects with mild, stable asthma inhaled budesonide (400 µg/d) for 8 d in a placebo-controlled, double-blind, randomized crossover study. On Day 7, subjects inhaled allergen, with bone marrow sampling before and 24 h after challenge. Budesonide inhalation significantly attenuated the allergen-induced early and late asthmatic responses, degree of increase in sputum and blood eosinophils, as well as the baseline numbers of total bone marrow CD34+ cells (p < 0.05), CD34+IL-3Ralpha + cells (p < 0.01) and IL-5-responsive Eo/B-CFU (p < 0.05). Allergen inhalation significantly increased Eo/B-CFU grown in the presence of IL-3, GM-CSF, or IL-5 alone (p < 0.05) and in combination (p < 0.01), as well as the number of CD34+IL-5Ralpha + cells (p < 0.01). However, these increases in Eo/B-CFU and CD34+IL-5Ralpha + cells were not affected by budesonide treatment. These data demonstrate that short-term inhaled budesonide treatment has a systemic effect in inhibiting the turnover of a subpopulation of bone-marrow-derived progenitors, but that inhalation of allergen overcomes this inhibitory effect.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
J. A. Denburg and S. F. van Eeden
Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology.
Eur. Respir. J., March 1, 2006; 27(3): 441 - 445.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Parameswaran, R. Watson, G. M. Gauvreau, R. Sehmi, and P. M. O'Byrne
The Effect of Pranlukast on Allergen-induced Bone Marrow Eosinophilopoiesis in Subjects with Asthma
Am. J. Respir. Crit. Care Med., April 15, 2004; 169(8): 915 - 920.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. C. Kips, B. J. O'Connor, S. J. Langley, A. Woodcock, H. A. M. Kerstjens, D. S. Postma, M. Danzig, F. Cuss, and R. A. Pauwels
Effect of SCH55700, a Humanized Anti-Human Interleukin-5 Antibody, in Severe Persistent Asthma: A Pilot Study
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1655 - 1659.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Shen, P. M. O'Byrne, R. Ellis, J. Wattie, C. Tang, and M. D. Inman
The Effects of Intranasal Budesonide on Allergen-induced Production of Interleukin-5 and Eotaxin, Airways, Blood, and Bone Marrow Eosinophilia, and Eosinophil Progenitor Expansion in Sensitized Mice
Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 146 - 153.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. H. Mwamtemi, K. Koike, T. Kinoshita, S. Ito, S. Ishida, Y. Nakazawa, Y. Kurokawa, K. Shinozaki, K. Sakashita, K. Takeuchi, et al.
An Increase in Circulating Mast Cell Colony-Forming Cells in Asthma
J. Immunol., April 1, 2001; 166(7): 4672 - 4677.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. M. GAUVREAU, L. J. WOOD, R. SEHMI, R. M. WATSON, S. C. DORMAN, R. P. SCHLEIMER, J. A. DENBURG, and P. M. O'BYRNE
The Effects of Inhaled Budesonide on Circulating Eosinophil Progenitors and Their Expression of Cytokines after Allergen Challenge in Subjects with Atopic Asthma
Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2139 - 2144.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. A. BECKY KELLY, W. W. BUSSE, and N. N. JARJOUR
Inhaled Budesonide Decreases Airway Inflammatory Response to Allergen
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 883 - 890.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society